A new analysis has shed light on the stark reality of the high cost of weight-loss medication, revealing that only the wealthiest individuals can reap any savings on their grocery bills. According to a study by consultancy Baringa, individuals would need a staggering discretionary income of nearly £100,000 per year to make a dent in their grocery expenses after shelling out £1,200 annually for GLP-1 medication. The findings have sparked concerns that the cost of these weight-loss medications is a "regressive tax on being thin," unfairly penalizing those who can least afford it. As Britain grapples with rising healthcare costs and obesity rates, the implications of this analysis raise important questions about accessibility and affordability of life-changing treatments.
Users need discretionary income of nearly £100,000 a year to make savings on their grocery spend after paying £1,200 for GLP-1s, analysis findsThe high cost of weight-loss medication is a “regressive tax on being thin” because the outlay outweighs any saving on food costs for all but the highest earners.Someone needs to have discretionary income of nearly £100,000 a year to actually save money after covering the £1,200 annual cost of GLP-1 medication, according to an analysis by the consultancy Baringa. Continue reading...
